Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Sodium chloride
Drug ID BADD_D02473
Description Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential Medicines.
Indications and Usage This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
Marketing Status approved; vet_approved
ATC Code A12CA01; B05CB01; B05XA03
DrugBank ID DB09153
KEGG ID D02056
MeSH ID D012965
PubChem ID 5234
TTD Drug ID D04YZL
NDC Product Code 76420-083; 80327-011; 82529-000; 10106-3301; 81861-0026; 82056-0001; 24208-277; 42829-001; 46163-300; 51662-1258; 51879-122; 52584-888; 52584-966; 57826-441; 0338-0160; 63323-093; 63323-187; 63323-632; 63323-924; 65219-222; 0409-1141; 69842-284; 0536-1254; 70529-022; 70529-049; 71872-7084; 79672-613; 80762-0010; 81826-001; 24600-1386; 17271-700; 24208-385; 52584-186; 0264-1800; 0264-2201; 0264-5804; 0264-7805; 0338-9151; 65219-472; 65282-1505; 65282-1510; 0404-9953; 69842-285; 70529-136; 70795-1120; 71872-7248; 76297-001; 80762-0012; 24600-1138; 0990-7730; 11822-0470; 49230-300; 0220-3593; 0220-3597; 0220-3599; 54973-4080; 59390-183; 0338-0047; 63323-623; 65219-226; 65219-468; 65219-474; 0404-9955; 68428-885; 70369-007; 70369-010; 54973-6433; 0338-0054; 62106-5206; 63323-090; 63323-186; 0363-5558; 0363-7500; 65219-470; 0409-1966; 0536-1253; 0641-6144; 73666-0580; 77267-007; 80771-000; 0990-7138; 55579-937; 17478-622; 50090-2488; 0220-3598; 51662-1577; 0264-7802; 58264-0135; 0338-0050; 0338-0051; 0338-0182; 0338-0553; 0338-9543; 0363-1505; 63323-088; 64117-867; 65219-220; 65219-230; 65219-232; 0404-9978; 80327-009; 11014-0075; 24874-0001; 49452-6690; 49452-6700; 0990-7983; 11822-0469; 17271-701; 42829-505; 51662-1318; 0264-7800; 0264-9375; 54973-4095; 55681-305; 0338-0186; 0338-0192; 63323-095; 63323-626; 0363-9050; 0409-4888; 0409-7101; 71872-7083; 73666-0550; 73666-0560; 73666-0570; 14639-6444; 70343-210; 70387-109; 11822-5458; 42829-003; 51662-1464; 0264-7806; 55154-4358; 0338-0162; 0338-0166; 63323-530; 65219-466; 0487-4301; 69626-0064; 69842-533; 70529-021; 76328-100; 10695-153; 24208-276; 0220-3586; 0220-3590; 51662-1342; 51879-191; 0264-5802; 55910-632; 0338-0056; 0338-9159; 65219-218; 65219-432; 67091-327; 70529-024; 71309-154; 0641-0497; 76472-1154; 76472-4096; 77333-835; 77333-844; 0990-6138; 51552-0077; 0990-7972; 0990-7985; 55154-9357; 0338-0048; 0338-0049; 59779-303; 63323-099; 0363-5557; 65219-224; 65219-228; 68428-061; 69842-473; 70529-023; 71872-7082; 0641-1512; 76472-4026; 80762-0011; 10106-3302; 24600-1382; 63822-0001; 51662-1522; 0363-0193; 62106-1058; 63323-139; 64253-202; 0404-9954; 68428-111; 68428-526; 0409-6660; 69842-472; 0990-7984; 69500-110; 70387-115; 17478-623; 42829-407; 42829-504; 49281-912; 0019-1188; 0220-3595; 0220-3600; 52584-109; 55154-0126; 58657-118; 0338-0043; 0338-0164; 0338-0196
UNII 451W47IQ8X
Synonyms Sodium Chloride | Sodium Chloride, (22)Na | Sodium Chloride, (24)NaCl
Chemical Information
Molecular Formula ClNa
CAS Registry Number 7647-14-5
SMILES [Na+].[Cl-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Mental fatigue19.21.02.012; 17.03.03.0060.000483%Not Available
Administration site erythema12.07.04.018; 08.02.04.018; 23.03.06.0210.001231%Not Available
Administration site extravasation12.07.04.019; 08.02.04.0190.000362%Not Available
Central nervous system vasculitis24.12.04.005; 17.08.02.029; 10.02.02.030--Not Available
Colorectal cancer recurrent07.21.01.003; 16.13.01.004--Not Available
Dysbiosis12.02.05.053; 07.11.01.0340.000241%Not Available
Extravasation of urine20.02.03.0180.000241%Not Available
Fear of injection19.06.03.016--Not Available
Gait inability17.02.05.069; 08.01.02.011--Not Available
Graves' disease10.04.08.014; 06.09.04.009; 05.02.02.009--Not Available
Heavy menstrual bleeding21.01.03.005--Not Available
Idiopathic intracranial hypertension17.07.02.011--Not Available
Infusion related hypersensitivity reaction12.02.05.055; 10.01.03.0580.000241%Not Available
Injection site discharge12.07.03.057; 08.02.03.057--Not Available
Lip erythema07.05.05.0280.000241%Not Available
Myelosuppression01.03.03.0150.000966%Not Available
Pharyngeal swelling22.04.05.028--Not Available
Salt intoxication14.05.04.0040.000241%Not Available
Treatment noncompliance12.09.02.006; 08.06.01.067--Not Available
Vancomycin infusion reaction23.03.06.028; 10.01.01.0480.000531%Not Available
Catheter site necrosis12.07.02.069; 08.02.02.069--Not Available
Colon cancer stage II16.13.01.006; 07.21.01.006--Not Available
The 17th Page    First    Pre   17    Total 17 Pages